6.
Chen H, Lee J, Wang Y, Huang D, Ambinder R, Hayward S
. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Proc Natl Acad Sci U S A. 1999; 96(16):9339-44.
PMC: 17784.
DOI: 10.1073/pnas.96.16.9339.
View
7.
Randerson J, Cawkwell L, Jack A, Lewis F, Johnson P, Evans P
. Fluorescent polymerase chain reaction of a panel of CA repeats on chromosome 6 in the indolent phase of follicular centre cell lymphoma. Br J Cancer. 1996; 74(6):942-6.
PMC: 2074751.
DOI: 10.1038/bjc.1996.461.
View
8.
Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S
. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol. 1993; 143(4):1044-9.
PMC: 1887050.
View
9.
Fan Y, Rizkalla K, William B, Engel C
. Jumping translocations of 11q in acute myeloid leukemia and 1q in follicular lymphoma. Cancer Genet Cytogenet. 2000; 118(1):35-41.
DOI: 10.1016/s0165-4608(99)00149-1.
View
10.
Sasajima Y, Yamabe H, Kobashi Y, Hirai K, Mori S
. High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am J Pathol. 1993; 143(5):1280-5.
PMC: 1887189.
View
11.
Gray B, Bent-Williams A, Wadsworth J, Maiese R, Bhatia A, Zori R
. Fluorescence in situ hybridization assessment of the telomeric regions of jumping translocations in a case of aggressive B-cell non-Hodgkin lymphoma. Cancer Genet Cytogenet. 1997; 98(1):20-7.
DOI: 10.1016/s0165-4608(96)00409-8.
View
12.
Tierney R, Steven N, Young L, Rickinson A
. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol. 1994; 68(11):7374-85.
PMC: 237180.
DOI: 10.1128/JVI.68.11.7374-7385.1994.
View
13.
. The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000; 50(9):696-702.
DOI: 10.1046/j.1440-1827.2000.01108.x.
View
14.
Akasaka T, Miura I, Takahashi N, Akasaka H, Yonetani N, Ohno H
. A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma results in replacement of the 5' regulatory region of BCL6 with a novel H4 histone gene. Cancer Res. 1997; 57(1):7-12.
View
15.
Suzuki R, Nakamura S
. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res. 1999; 23(7):615-24.
DOI: 10.1016/s0145-2126(98)00194-5.
View
16.
Harris N, Jaffe E, STEIN H, Banks P, Chan J, Cleary M
. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84(5):1361-92.
View
17.
Stoffel A, Rao P, Louie D, Krauter K, Liebowitz D, Koeppen H
. Chromosome 18 breakpoint in t(11;18)(q21;q21) translocation associated with MALT lymphoma is proximal to BCL2 and distal to DCC. Genes Chromosomes Cancer. 1999; 24(2):156-9.
View
18.
Kelleher C, Dreyfus D, Jones J, Gelfand E
. EBV infection of T cells: potential role in malignant transformation. Semin Cancer Biol. 1996; 7(4):197-207.
DOI: 10.1006/scbi.1996.0027.
View
19.
Hamilton-Dutoit S, Pallesen G, Karkov J, Skinhoj P, Franzmann M, Pedersen C
. Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in-situ hybridisation. Lancet. 1989; 1(8637):554-2.
DOI: 10.1016/s0140-6736(89)90093-7.
View
20.
Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M
. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood. 1995; 86(5):1954-60.
View